13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
Clifford Chance advises Keymed Biosciences Inc. on out-licensing transaction with Belenos Biosciences
Global law firm Clifford Chance has advised Keymed Biosciences (Chengdu) Co., Ltd. on its out-licensing transaction with Belenos Biosciences, Inc.to…
Kirkland Advises Carlyle on $3.8 Billion Acquisition of Baxter’s Kidney Care Segment
Kirkland & Ellis is advising global investment firm Carlyle (NASDAQ: CG) on the $3.8 billion acquisition of global medtech company…
Kirkland Advises Interogo Holding on Acquisition of Minority Investment in Q-Park
Kirkland & Ellis is advising Interogo Holding, a foundation-owned investment group, on its acquisition of a 12.25% minority investment in…
Latham & Watkins Represents Life Time Group Holdings, Inc. in Public Offering of 12 Million Shares of Common Stock
Firm advises the health and wellness company on the offering. Life Time Group Holdings, Inc. (NYSE: LTH) has announced the…
Latham & Watkins Advises scPharmaceuticals on Growth Financings
Multidisciplinary team represented the life science company in a combined secured financing (senior secured term loan and royalty) totaling up…
Latham & Watkins Represents Shift4 Payments, Inc. in US$1.1 Billion Senior Notes Offering
Firm represents the integrated payments and commerce technology company in the offering. Shift4 Payments, Inc. (NYSE: FOUR), a leader in…
